Center for Excellence in Molecular Cell Science (CEMCS, or known as Shanghai Institute of Biochemistry and Cell Biology), is a world-renowned institution founded by the Chinese Academy of Sciences (CAS). CEMCS seeks preeminence in exploring fundamental knowledge about nature and human diseases. It is dedicated to fostering innovative discoveries and inspiring an exciting education culture for nurturing future talents. To know more about us, please go to: http://cemcs.cas.cn/.
We are now seeking outstanding scholars to join us as Principal Investigators who work on:
1) RNA biology or state-of-the-art RNA method development, including (but not limited to): Systems/AI RNA biology, RNA imaging, RNA immunology, noncoding RNAs, synthetic RNA biology, macromolecule delivery, translation regulation, RNA structural biology.
2) Cell biology, including (but not limited to): Cell Fate Plasticity, Cell Engineering, in vivo Imaging
3) Immunology, including (but not limited to): Immune Aging, Vaccine Immunology, Cancer Immunology
4) Cancer biology, including (but not limited to): Cancer Signaling, Cancer Metabolism, and Cancer Therapy
Applicants must have (1) a Ph.D. degree, (2) sufficient research experience to demonstrate his/her significant accomplishments, (3) outstanding potential that fits the main research directions mentioned above.
How to Apply:
Curriculum vitae with a recent photo, a list of publications, a brief summary of previous accomplishments and a future research plan, and a list of three references should be sent to: Mrs. Yibin Yu, Secretary, Talents Searching Committee, CEMCS at firstname.lastname@example.org. (with the subject title: “PI position (code:1014)+Name”) This job posting is valid until the positions are filled.
Priority consideration will be given to applications that are complete by Dec. 31, 2023. The anticipated starting date of the appointment is Jun. 30, 2024.
Salary and Package: CEMCS provides a highly competitive salary and housing subsidies, excellent laboratory spaces, and generous start-up funds.
We encourage intellectual freedom. Innovative and creative ideas are highly valued.